Cite
HARVARD Citation
Ward, M. et al. (2017). Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes. Scientific reports. 7 (1), pp. 1-14. [Online].